Cav3.1 Ca2+ Channel (AA 2052-2172), (C-Term) antibody
-
- Target
- Cav3.1 Ca2+ Channel
- Binding Specificity
- AA 2052-2172, C-Term
- Reactivity
- Mouse, Human, Rat
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- Un-conjugated
-
Application
- Immunohistochemistry (IHC), Western Blotting (WB)
- Specificity
- Reacts withhuman, mouse, and rat Cav3.1. Does not cross-react with Cav3.2.
- Purification
- Purified
- Immunogen
- Fusion protein corresponding to aa 2052-2172 (cytoplasmic C-terminus) of mouse Cav3.1 (accession no. NP_001106284.1).
- Clone
- S178A-9
- Isotype
- IgG1
-
-
- Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1 - 2 μg/mL) IHC(1 - 10 μg/mL)
Positive control: Rat brain membranes - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, 50 % glycerol
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Dilute in PBS or medium that is identical to that used in the assay system.
- Storage
- -20 °C
- Storage Comment
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- Cav3.1 Ca2+ Channel
- Background
-
Ion channels are integral membrane proteins that help establish and control the small voltage gradient across the plasma membrane of living cells by allowing the flow of ions down their electrochemical gradient. Cav3.1 is a low-voltage activated T-type calcium channel expressed throughout the body. Drugs that block T-type calcium channels are used as antihypertensives and anti-epileptics and possibly in some anesthetics and antipsychotics.
Voltage-dependent T-type calcium channel subunit alpha-1G Cav3.1c NBR13 Voltage-gated calcium channel subunit alpha Cav3.1 Gene name: CACNA1G, KIAA1123 Ca(V)T.1, Cav3.1, NBR13 - Gene ID
- 8913
- UniProt
- O43497
-